These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34733376)

  • 1. Perioperative Circulating Tumor Cells (CTCs), MCTCs, and CTC-White Blood Cells Detected by a Size-Based Platform Predict Prognosis in Renal Cell Carcinoma.
    Wang Z; Zhang P; Chong Y; Xue Y; Yang X; Li H; Wang L; Zhang Y; Chen Q; Li Z; Xue L; Li H; Chong T
    Dis Markers; 2021; 2021():9956142. PubMed ID: 34733376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
    Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
    Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of circulating tumour cells (CTCs) and CTC white blood cell clusters in patients with renal cell carcinoma.
    Guan Y; Xu F; Tian J; Gao K; Wan Z; Wang Y; Gao M; Wang Z; Chong T
    BMC Cancer; 2021 Jul; 21(1):826. PubMed ID: 34271857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer.
    Chen K; Chen Z; Ou M; Wang J; Huang X; Wu Y; Zhong W; Yang J; Huang J; Huang M; Pan D
    Clinics (Sao Paulo); 2022; 77():100070. PubMed ID: 36087570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC.
    Wang ZL; Zhang P; Li HC; Yang XJ; Zhang YP; Li ZL; Xue L; Xue YQ; Li HL; Chen Q; Chong T
    Cancer Biol Ther; 2019; 20(4):505-512. PubMed ID: 30359544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients.
    Weng X; YangYang ; Cai Y
    Dis Markers; 2022; 2022():5188006. PubMed ID: 35140820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two detection systems for circulating tumor cells among patients with renal cell carcinoma.
    Bai M; Zou B; Wang Z; Li P; Wang H; Ou Y; Cui K; Bian J; Li S; Xu X
    Int Urol Nephrol; 2018 Oct; 50(10):1801-1809. PubMed ID: 30120680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Values of Circulating Tumor Cells and T Lymphocyte Subsets in Predicting a Prognosis of Lung Cancer.
    Liu X; Yan X; Li J; Mao W; Jiang F
    Clin Lab; 2024 Oct; 70(10):. PubMed ID: 39382904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-therapeutic circulating tumor cell-associated white blood cell clusters predict poor survival in patients with advanced driver gene-negative non-small cell lung cancer.
    Wang Y; Liu Y; Zhang Z; Lu B; Gao Y; Tong L; Hu M; Lin PP; Li B; Zhang T
    BMC Cancer; 2023 Jun; 23(1):578. PubMed ID: 37349714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer.
    Xu Y; Ren X; Jiang T; Lv S; Gao K; Liu Y; Yan Y
    BMC Cancer; 2023 May; 23(1):475. PubMed ID: 37226235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma.
    Song J; Yu Z; Dong B; Zhu M; Guo X; Ma Y; Zhao S; Yang T
    World J Surg Oncol; 2021 May; 19(1):156. PubMed ID: 34034739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative Detection of Circulating Tumor Cells in Radical or Partial Nephrectomy for Renal Cell Carcinoma.
    Haga N; Onagi A; Koguchi T; Hoshi S; Ogawa S; Akaihata H; Hata J; Hiraki H; Honda R; Tanji R; Matsuoka K; Kataoka M; Sato Y; Ishibashi K; Kojima Y
    Ann Surg Oncol; 2020 Apr; 27(4):1272-1281. PubMed ID: 31832914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.
    Han L; Li YJ; Zhang WD; Song PP; Li H; Li S
    Medicine (Baltimore); 2019 Feb; 98(6):e13921. PubMed ID: 30732126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer.
    Cai J; Huang L; Huang J; Kang L; Lin H; Huang P; Zhu P; Wang J; Dong J; Wang L; Xian CJ
    J Cell Biochem; 2019 Apr; 120(4):4935-4941. PubMed ID: 30260024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis.
    Tariki MS; Barberan CCG; Torres JA; Ruano APC; Ferreira Costa DJ; Braun AC; da Silva Alves V; de Cássio Zequi S; da Costa WH; Fay AP; Torrezan G; Carraro DM; Domingos Chinen LT
    Pathol Res Pract; 2024 Jan; 253():154918. PubMed ID: 37995423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer.
    Li W; Zhang X; Yang Y; Lin J; Zhou K; Sun R; Dang C; Diao D
    Sci Rep; 2024 Jun; 14(1):12758. PubMed ID: 38830909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.